False-positive results in neuroblastoma screening: The parents' view

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 1, 2003, Pages 14-18

  Dobrovoljski, Gabriele ^b   Kerbl, Reinhold ^a   Strobl, Carola ^b   Schwinger, Wolfgang ^b   Dornbusch, Hans Jürgen ^b   Lackner, Herwig ^b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b NONE

Author keywords

Childhood; False positive; Neuroblastoma screening; Parents; Psychological consequences

Indexed keywords

CATECHOLAMINE; VANILMANDELIC ACID;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FEMALE; GAS CHROMATOGRAPHY; HEALTH PROGRAM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERVIEW; LABORATORY DIAGNOSIS; MALE; MASS SPECTROMETRY; NEUROBLASTOMA; PARENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ANXIETY; CATECHOLAMINES; CHILD; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MASS SCREENING; NEUROBLASTOMA; PARENTS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; STRESS, PSYCHOLOGICAL;

EID: 0037230052     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200301000-00005     Document Type: Article

References (21)

1. Sawada T, Sugimoto T, Kawakatsu H, et al. Mass screening for neuroblastoma in Japan. Pediatr Hematol Oncol 1991;8:93-109.
2. Schilling FH, Parker C. Mass screening for neuroblastoma: The European experience. In Brodeur GM, Sawada T, Tsuchida Y, Voûte PA, eds. Neuroblastoma. Amsterdam: Elsevier; 2000:281-92.
3. Bell S, Parker L, Cole M, et al. Screening infants for neuroblastoma: the parents' perspective in false-positive cases. Pediatr Hematol Oncol 1994;11:157-63.
4. Report of the 1998 Consensus Conference on Neuroblastoma Screening. Med Pediatr Oncol 1999;33:357-9.
5. Ater JL, Gardner KL, Foxhall LE, et al. Neuroblastoma screening in the United States: results of the Texas Outreach Program for Neuroblastoma Screening. Cancer 1998;82:1593-602.
6. Kerbl R, Urban C. Neuroblastoma screening in the United States [letter]. Cancer 1998;83:2047-8.
7. Bell S, Parker L, Craft AW, et al. False-positive results in a neuroblastoma screening programme. Med Pediatr Oncol 1994;22:181-6.
8. Mathieu P, Frappaz D, Chauvin F, et al. A 5-year neuroblastoma screening feasibility study in France. Methodology and preliminary observations. Early Hum Dev 1996;46:177-96.
9. Kerbl R, Urban C, Ladenstein R, et al. Neuroblastoma screening in infants postponed after the sixth month of life: A trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features. Med Pediatr Oncol 1997;29:1-10.
10. Fauler G, Leis HJ, Huber E, et al. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS. J Mass Spectrom 1997;32:507-14.
11. Gustafsson O, Theorell T, Norming U, et al. Psychological reactions in men screened for prostate cancer. Br J Urol 1995;75:631-6.
12. Wardle FJ, Collins W, Pernet AL, et al. Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst 1993;85:653-7.
13. Cockburn J, Staples M, Hurley SF, et al. Psychological consequences of screening mammography. J Med Screen 1994;1:7-12.
14. Gilbert FJ, Cordiner CM, Affleck IR, et al. Breast screening: the psychologic sequelae of false-positive recall in women with and without a family history of breast cancer. Eur J Cancer 1998;34:2010-4.
15. Olsson P, Armelius K, Nordahl G, et al. Women with false-positive screening mammograms: how do they cope? J Med Screen 1999;6:89-93.
16. Scaf KW, Sanderman R, van de Wiel HB, et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997;51:705-10.
17. Gram IT, Lund E, Slenker SE. Quality of life following a false-positive mammogram. Br J Cancer 1990;62:1018-22.
18. Bodegard G, Fyro K, Larsson A. Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism. Acta Paediatr Scand 1983(suppl);304:1-21.
19. Fyro K, Bodegard G. Four-year follow-up of psychologic reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand 1987;76:107-14.
20. Woods WG, Tuchman M, Robison LL. et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 1996;348:1682-7.
21. Gray JAM, Piribauer F. Realising the potential benefit of screening. Comment on the outcomes of the first Austrian Screening Guidelines Consensus Conference. Wien Klin Wochenschr 2001;113:4-6.